VOYA Investment Management
FOLD

VOYA Investment Management’s Amicus Therapeutics FOLD Stock Holding History

VOYA Investment Management’s Portfolio FOLD Stock Details FOLD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$715K Sell
49,413
-58,018
-54% -$832K ﹤0.01% 1582
2025
Q4 		$1.53M Sell
107,431
-428,253
-80% -$4.21M ﹤0.01% 1326
2025
Q3 		$4.22M Sell
535,684
-90,062
-14% -$641K ﹤0.01% 935
2025
Q2 		$3.59M Buy
625,746
+41,901
+7% +$270K ﹤0.01% 1079
2025
Q1 		$4.76M Sell
583,845
-92,508
-14% -$856K 0.01% 992
2024
Q4 		$6.37M Sell
676,353
-743,492
-52% -$7.73M 0.01% 885
2024
Q3 		$15.2M Buy
1,419,845
+106,063
+8% +$1.16M 0.02% 635
2024
Q2 		$13M Buy
1,313,782
+261,773
+25% +$2.69M 0.01% 680
2024
Q1 		$12.4M Buy
1,052,009
+62,403
+6% +$798K 0.01% 684
2023
Q4 		$14M Buy
989,606
+238,033
+32% +$2.7M 0.01% 631
2023
Q3 		$9.14M Sell
751,573
-139,308
-16% -$1.8M 0.01% 725
2023
Q2 		$11.2M Buy
890,881
+158,488
+22% +$1.88M 0.01% 687
2023
Q1 		$8.12M Sell
732,393
-8,919
-1% -$110K 0.01% 794
2022
Q4 		$9.05M Buy
741,312
+170,357
+30% +$1.92M 0.01% 754
2022
Q3 		$5.96M Buy
570,955
+30,848
+6% +$344K 0.01% 887
2022
Q2 		$5.8M Buy
540,107
+434,825
+413% +$3.58M 0.01% 685
2022
Q1 		$997K Sell
105,282
-299,608
-74% -$2.81M ﹤0.01% 1474
2021
Q4 		$4.68M Sell
404,890
-377,125
-48% -$4.2M 0.01% 865
2021
Q3 		$7.47M Sell
782,015
-43,739
-5% -$447K 0.02% 695
2021
Q2 		$7.96M Buy
825,754
+97,513
+13% +$952K 0.02% 696
2021
Q1 		$7.2M Buy
728,241
+44,254
+6% +$685K 0.01% 702
2020
Q4 		$15.8M Sell
683,987
-324,557
-32% -$6.64M 0.03% 408
2020
Q3 		$14.2M Sell
1,008,544
-109,562
-10% -$1.6M 0.03% 427
2020
Q2 		$16.9M Sell
1,118,106
-281,357
-20% -$3.43M 0.04% 376
2020
Q1 		$12.9M Sell
1,399,463
-99,969
-7% -$950K 0.03% 405
2019
Q4 		$14.6M Sell
1,499,432
-782,365
-34% -$7.16M 0.03% 482
2019
Q3 		$18.3M Buy
2,281,797
+481,964
+27% +$5.23M 0.04% 414
2019
Q2 		$22.5M Sell
1,799,833
-96,261
-5% -$1.22M 0.05% 358
2019
Q1 		$25.8M Buy
1,896,094
+286,786
+18% +$3.5M 0.06% 301
2018
Q4 		$15.4M Sell
1,609,308
-87,012
-5% -$956K 0.04% 426
2018
Q3 		$20.5M Buy
1,696,320
+362,824
+27% +$5.07M 0.04% 426
2018
Q2 		$20.8M Sell
1,333,496
-45,680
-3% -$691K 0.04% 426
2018
Q1 		$20.7M Buy
1,379,176
+163,937
+13% +$2.49M 0.04% 413
2017
Q4 		$17.5M Buy
1,215,239
+1,139,120
+1,496% +$15.7M 0.04% 456
2017
Q3 		$1.15M Buy
76,119
+10,046
+15% +$133K ﹤0.01% 1325
2017
Q2 		$665K Buy
66,073
+11,991
+22% +$96.5K ﹤0.01% 1653
2017
Q1 		$386K Sell
54,082
-1,600,440
-97% -$10.1M ﹤0.01% 1882
2016
Q4 		$8.22M Buy
1,654,522
+16,051
+1% +$111K 0.02% 644
2016
Q3 		$12.1K Sell
1,638,471
-271,725
-14% -$1.84M 0.02% 513
2016
Q2 		$10.4M Buy
1,910,196
+565,050
+42% +$3.95M 0.03% 554
2016
Q1 		$11.4M Buy
1,345,146
+471,285
+54% +$3.34M 0.03% 500
2015
Q4 		$8.48M Buy
873,861
+673,950
+337% +$6.07M 0.02% 606
2015
Q3 		$2.8M Buy
199,911
+153,100
+327% +$2.4M 0.01% 923
2015
Q2 		$662K Buy
+46,811
New +$563K ﹤0.01% 1721

Other funds holding FOLD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

VOYA Investment Management's FOLD Position: Q1 2026 in Review

VOYA Investment Management reduced its Amicus Therapeutics (FOLD) stake by 54% in Q1 2026, selling an estimated $832K and leaving 49,413 shares worth $715K. The position accounts for ﹤0.01% of the portfolio, ranked #1582.

VOYA Investment Management first reported a position in FOLD in Q2 2015 and has held it in 44 quarters since. The position peaked at $25.8M in Q1 2019. 298 funds tracked by Wall St. Rank hold FOLD as of Q1 2026.

  • VOYA Investment Management held 49,413 shares of Amicus Therapeutics worth $715K as of Q1 2026.
  • VOYA Investment Management sold 58,018 Amicus Therapeutics shares in Q1 2026, an estimated $832K.
  • Amicus Therapeutics made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1582 holding.
  • VOYA Investment Management first reported a position in Amicus Therapeutics in Q2 2015 and has held it in 44 quarters since.
  • VOYA Investment Management's Amicus Therapeutics position peaked at $25.8M in Q1 2019.
  • 298 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.